Core Viewpoint - The stock of Hahai Huadong (301137.SZ) experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 30% over two consecutive trading days on October 9 and 10, 2025, prompting regulatory scrutiny [1] Company Information - The company acknowledged media reports regarding its products being applicable in controlled nuclear fusion projects, confirming that while its products can be used in such projects, the revenue generated from these applications accounts for less than 1% of total revenue [1] - Following an internal review, the company, its controlling shareholders, and actual controllers confirmed that there are no undisclosed significant matters related to the company, nor are there any major matters in the planning stage [1]
哈焊华通(301137.SZ)：目前用于可控核聚变的产品收入占总收入比例低于1%